Pfizer Eraxis pricing
Executive Summary
Pfizer launches the antifungal Eraxis (fluconazole) the week of May 15. The wholesale acquisition cost is $90 per 50 mg vial plus diluent, although the hospital price will vary depending on location. FDA approved Eraxis Feb. 17 to treat a variety of types of Candida infections (1"The Pink Sheet" Feb. 22, 2006, p. 3). The average wholesale price for the firm's other Candida infection treatment Vfend (voriconazole) is approximately $110 for 200 mg...
You may also be interested in...
Eraxis Approval May Position Pfizer To Reclaim Diflucan Market Share
FDA approval of Pfizer's echinocandin antifungal Eraxis may represent an opportunity for the company to begin to replace the loss of branded Diflucan
EU’s SCCS Finds Endocrine-Disrupting Evidence Inconclusive In UV Filter Reassessments
While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.
US FDA Urges COVID-19 Transmission Risk Mitigation In Cell And Gene Therapy Manufacturing
The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: